Stephen Kent

[Stephen Kent @ProfStephenKent]

Strong link between early viral load reduction by anti-COVID treatments and clinical efficacy.
Helps rapidly progress better treatments.
Bravo, great work by Khoury, Davenport and team. @IAP_Sydney @TheDohertyInst @KirbyInstitute @viralvaxlab https://t.co/aRj6kWHHEG

[Stephen Kent @ProfStephenKent]

@DrRenly This wasted effort is against every principle of scientific progress and scientific workforce development #MRFF. FIX IT. Fund the next best 150 grants WITHOUT reapplication. @sciencegovau @edhusicMP @MarkPButler

[Stephen Kent @ProfStephenKent]

Great work team! Yes, keep getting your vaccines people. Although the difference between WT and variant boosters is pretty subtle in some healthy subjects, the variant booster will help some vulnerable groups stay out of hospital.

[Deborah Cromer @DebCro]

Get boosted! Our new research in Nature Medicine shows both normal and bivalent boosters increase antibody levels, though variant boosters give on average 60% more antibodies. #COVID19Abs https://t.co/oORo4o68CB @IAP_Sydney @KirbyInstitute @ProfStephenKent

[Stephen Kent @ProfStephenKent]

This is super important. Severe COVID is THE major issue today. Neutralising antibodies protect against severe COVID.

[Megan Steain @m_steain]

Do you like your covid-19 vaccines to give you a good dose of neutralising antibodies? You should because we've shown they correlate not only with protection from symptomatic but also severe disease! Another great collab with ⁦@DebCro⁩ https://t.co/1BEZACwiYX

[Nature Immunology @NatImmunol]

Research Highlight https://t.co/552sVFkGkM on a paper by Juno and colleagues that examines T cells frequency and phenotype after Delta and Omicron breakthrough infection in previously vaccinated individuals.

[Stephen Kent @ProfStephenKent]

Crazy strong link between Nab and protection from severe COVID, p <2.2e-16. Superb work by @DebCro, the Davenport group and collaborators. @KirbyInstitute @TheDohertyInst https://t.co/IwZOMtjcgm

[Deborah Cromer @DebCro]

Our latest preprint shows that neutralising antibodies predict protection from severe COVID-19. Great collaborating with @ProfStephenKent @m_steain on this important work from the @KirbyInstitute https://t.co/aRHpqLfucq

[Stephen Kent @ProfStephenKent]

More brilliant work from David Khoury and team. Elegantly reconciles protective immunity by Nab from multiple angles.
Correlates of protection, thresholds of protection, and immunobridging in SARS-CoV-2 infection https://t.co/lku7bkbP4i

[Stephen Kent @ProfStephenKent]

@vanGilsLab @hecklab @amsterdamumc Nice Marit and team. MS is a good way to follow clones over time too. https://t.co/82El2DsIqa Looking forward to your link up with Mabs.

[Stephen Kent @ProfStephenKent]

@Hyonxhi @SciImmunology Fantastic study, superbly led by HX and Adam and amazingly well supported by the whole team. Go BRMs and their Abs! Likely where the action is at controlling Flu, COVID-19 and other acute respiratory pathogens. You should be lodging a few as we speak HX!

[Stephen Kent @ProfStephenKent]

@ProfPCDoherty Or preferentially boost antibodies to conserved unhelpful epitopes in original strain? (Imprinting/Original Ag sin) https://t.co/XQ2pyZicv2

[Stephen Kent @ProfStephenKent]

@c_phetsouphanh @NatImmunol @DavidDarley_ @Dan_B_Wilson @GregDore2 @KirbyInstitute @TheDohertyInst Great work Chan and team. Super insightful into long covid. Honoured to have been involved. #viralvaxlab

[Chan Phetsouphanh PhD @c_phetsouphanh]

On paper on immune dysfunction during #longCOVID
is now publish @NatImmunol.

@DavidDarley_ @Dan_B_Wilson @GregDore2 @KirbyInstitute @KentLaboratory @TheDohertyInst
https://t.co/P3U2KZ7fJV

[Stephen Kent @ProfStephenKent]

@viralvaxlab @MariosKoutsakos @WenShiLee Nice thread! Couldn’t have been done without clever immunologists, cool assays, and super dedicated participants who were so altruistic. Another big inroad into covid immunity with the Davenport group.

[Stephen Kent @ProfStephenKent]

Nervous about the ability of new vaccines to combat COVID variants. Our immune systems can recognise the old strains better than the new ones, called "immune imprinting". Discussion piece out in Trends in Immunology. https://t.co/IPciLFvVGD @WheatleyAtotheK @scientist_JJ @Hyonxhi

[Stephen Kent @ProfStephenKent]

Super proud of Jen, Hyon-Xhi and Amy on the announcement of their NHMRC Investigator awards. Richly deserved in a crazy crazy tough system. Allows them to dream even bigger. Will be exciting to watch over the next 5 years. Congrats @scientist_JJ @Hyonxhi @AmyWChung

[Stephen Kent @ProfStephenKent]

Congratulations, especially to Adam and the team @KentLaboratory

[Wai-Hong Tham @tham_lab]

We are making antibody cocktails against #COVID19 !! 🙏 #MRFF funding to manufacture monoclonal antibody treatments into clinical trials. Great collaborative outcomes between @WEHI_research @TheDohertyInst @BurnetInstitute @KirbyInstitute @CSL AffinityBio and @CSIRO

[Stephen Kent @ProfStephenKent]

The Kent lab is hiring! We're looking for a project manager to help co-ordinate our recently funded next-generation COVID-19 clinical vaccine development project 💉
https://t.co/rPzj8o5Eyz

More information and application below 👇
https://t.co/DrfCqHIf2N